This inventor holds 6 USPTO granted patents and 3 published patent applications. Top assignees: Chongqing Genrix Biopharmaceutical Co., Ltd., Beijing Wisdomab Biotechnology Co., Ltd., Genrix (Shanghai) Biopharmaceutical Co. Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 5 
4 out of 4 
2 out of 5 Years Active: 2025-2026
Title: Junjie Hu: Innovator in Biopharmaceuticals
Introduction
Junjie Hu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapies. With a total of 6 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents is the "BCMA x CD3 T Bispecific Cell Engager," which focuses on the anti-CD3E/BCMA bispecific antibody and its applications. This invention showcases his commitment to advancing therapeutic options for patients.
Career Highlights
Junjie Hu has worked with Chongqing Genrix Biopharmaceutical Co., Ltd., where he has contributed to various projects aimed at improving healthcare solutions. His experience in this company has allowed him to refine his skills and innovate within the biopharmaceutical sector.
Collaborations
He has collaborated with notable colleagues such as Shunan Wan and Yulan Liu, further enhancing the collaborative spirit within his field. Their joint efforts have led to advancements in biopharmaceutical research and development.
Conclusion
Junjie Hu's contributions to biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative medical solutions that can benefit many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile